JDK, a leading pharmaceutical company specializing in the development of pharmaceutical intermediates and basic chemicals, has recently announced the launch of their high-quality Qibanqing Granules. T

JDK Introduces New Tyramine Hydrochloride Pharmaceutical Intermediate JDK, a leading chemical company specializing in pharmaceutical intermediates and basic chemicals, has recently announced the intr

JDK Develops Breakthrough Pharmaceutical Intermediate for Treatment of Schizophrenia JDK, a leading company specializing in the development of pharmaceutical intermediates and basic chemicals, has ma

JDK, a leading pharmaceutical company specializing in the development of pharmaceutical intermediates and basic chemicals, has recently made a major breakthrough with the development of a new drug com

High-Quality Poultry Sini Soup: A New Addition to JDK's Product Line JDK, a leading company specializing in pharmaceutical intermediates and basic chemicals, has recently introduced a new product to

JDK Launches L-Tryptophan 60% Feed Grade as Part of their Ongoing Commitment to Providing High-Quality Pharmaceutical Intermediates and Basic Chemicals As a leading company in the development of phar

JDK, a company recognized for its specialized and interdisciplinary technical talents, has been focusing on the development of pharmaceutical intermediates and basic chemicals. In line with this, the

JDK, a company with a professional team equipped with specialized and interdisciplinary technical talents, has been focusing on the development of pharmaceutical intermediates and basic chemicals. One

JDK, a leading company in the development of pharmaceutical intermediates and basic chemicals, has recently achieved the CE certification for its Gamma Aminobutyric Acid product. This certification is

JDK, a leading company in the pharmaceutical and chemical industry, has recently announced that their poultry Sini Soup product has received CE Certification. This certification signifies that the pro